Skip to main content

 Treat your central sleep apnea patients–without masks or medications–with the remedē® System

Clinically proven to reduce the effects of CSA

The remedē® System is a proven, implantable sleep therapy specifically designed for treating Central Sleep Apnea (CSA) in a way that closely resembles the body’s natural physiology. It has demonstrated consistent and sustained long-term safety and effectiveness benefits that have shown to reduce the severity of CSA, improve sleep, breathing and quality of life.1

78% of patients reported quality of life improvement using the Patient Global Assessment1

96 percent pie chart

96% reduction in the median Central Apnea Index at 1 year2

95% of patient reported they would “elect to have the medical procedure again”1

5 years

Improvements in sleep
disordered breathing
and quality sustained
out to 5 years2

See Complete STudy Results

remedē Patient Pathway

The remedē patient pathway is an educational service providing resources for screening, patient selection, device implant and therapy optimization and follow up. 

Access Patient Pathway
  1. Costanzo MR, Ponikowski P, Javaheri S, et al. Sustained Twelve Month Benefit of Phrenic Nerve Stimulation for Central Sleep Apnea. Am J Cardiol. 2018. pii: S0002-9149(18)30258-3. doi: 10.1016/j.amjcard.2018.02.022.
  2. Costanzo MR, Javaheri S, Ponikowski P, et al. Transvenous Phrenic Nerve Stimulation for Treatment of Central Sleep Apnea: Five-Year Safety and Efficacy Outcomes. Nat Sci Sleep. 2021;13:515-526